Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

G3R1S6 (G3R1S6_GORGO) Gorilla gorilla gorilla (Western lowland gorilla)

phosphatidylinositol-4,5-bisphosphate 3-kinase UniProtKBInterProSTRINGInteractive Modelling

1068 aa; Sequence (Fasta) ; 13 identical sequences

Available Structures

103 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
PI3Ka H1047R co-crystal structure with inhibitor in cryptic pocket near H1047R (compound 12). Heteromer
P27986; P42336;
1-1068
1LT;YQB;
Assess
Crystal Structure of PI3Kalpha Heteromer
P27986; P42336;
3-1065
PO4;GOL;
Assess
Crystal Structure of PI3Kalpha in complex with the inhibitor NVP-BYL719 Heteromer
P27986; P42336;
3-1065
1LT;NA;
Assess
PI3Ka H1047R co-crystal structure with inhibitors in two cryptic pockets (compounds 4 and 5). Heteromer
P27986; P42336;
2-1064
YO4;YOR;YNZ;
Assess
PI3Ka H1047R co-crystal structure with inhibitor in cryptic pocket near H1047R (compound 4). Heteromer
P27986; P42336;
2-1064
YO4;YNZ;
Assess
STX-478, a Mutant-Selective, Allosteric Inhibitor bound to H1047R PI3Kalpha Heteromer
P27986; P42336;
2-1063
10×EDO;X3N;ZWE;
Assess
Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse … Heteromer
P27986; P42336;
2-1062
GOL;5XV;
Assess
Crystal structure of human T1061E PI3Kalpha in complex with its regulatory subunit and the inhibito… Heteromer
P27986; P42336;
2-1062
MWF;EDO;PGE;CL;
Assess
p110alpha/p85alpha with compound 5 Heteromer
P23727; P42336;
2-1062
5H2;
Assess
Co-crystal Structures of the Lipid Kinase PI3K alpha with Pan and Isoform Selective Inhibitors Heteromer
P27986; P42336;
2-1061
SCN;1LT;
Assess
Crystal Structure of a novel tetrahydropyrazolo[1,5-a]pyrazine in an engineered PI3K alpha Heteromer
P27986; P42336;
2-1061
3K6;
Assess
Co-crystal Structure of Lipid Kinase PI3K alpha with a selective phosphatidylinositol-3 kinase alph… Heteromer
P27986; P42336;
2-1061
4Q2;
Assess
STX-478, a Mutant-Selective, Allosteric Inhibitor bound to PI3Kalpha Heteromer
P27986; P42336;
2-1061
X3N;ZWE;
Assess
Crystal structure of p110alpha H1047R mutant in complex with niSH2 of p85alpha and the drug wortman… Heteromer
P27986; P42336;
5-1062
KWT;
Assess
Crystal structure of PI3K alpha with PI3K delta inhibitor Heteromer
P27986; P42336;
2-1059
6CY;
Assess
PI3Ka H1047R co-crystal structure with inhibitor in cryptic pocket (compound 5). Heteromer
P27986; P42336;
2-1059
YOR;YNZ;
Assess
Crystal structure of p110alpha H1047R mutant in complex with niSH2 of p85alpha Heteromer
P27986; P42336;
5-1062
Assess
The co-structure of (R)-4-(6-(1-(cyclopropylsulfonyl)cyclopropyl)-2-(1H-indol-4-yl)pyrimidin-4-yl)-… Heteromer
P27986; P42336;
2-1057
8DV;
Assess
Crystal Structure of PI3Kalpha in complex with fragment 23 Heteromer
P27986; P42336;
1-1056
SOA;
Assess
Crystal Structure of PI3Kalpha in complex with fragment 10 Heteromer
P27986; P42336;
3-1058
71N;
Assess
Structure of p110alpha/niSH2 - vector data collection Heteromer
P27986; P42336;
2-1057
144;SO4;
Assess
Crystal Structure of PI3Kalpha in complex with fragments 6 and 24 Heteromer
P27986; P42336;
1-1054
70W;70V;CL;
Assess
Crystal Structure of PI3Kalpha in complex with fragments 17 and 27 Heteromer
P27986; P42336;
1-1054
71A;71B;
Assess
Crystal Structure of PI3Kalpha in complex with fragment 22 Heteromer
P27986; P42336;
1-1054
71F;
Assess
Crystal Structure of PI3Kalpha in complex with fragments 19 and 28 Heteromer
P27986; P42336;
1-1054
71G;ES3;
Assess
Co-structure Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform complex… Heteromer
P27986; P42336;
2-1054
ZUO;
Assess
Crystal structure of PI3Kalpha in complex with fragments 7 and 11 Heteromer
P27986; P42336;
1-1053
EPE;70S;FB1;
Assess
Crystal Structure of PI3Kalpha in complex with fragments 12 and 15 Heteromer
P27986; P42336;
2-1054
71M;LUZ;
Assess
Crystal Structure of PI3Kalpha in complex with fragment 14 Heteromer
P27986; P42336;
1-1053
71L;
Assess
Co-structure of Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform and … Heteromer
P27986; P42336;
2-1053
ZTV;SO4;
Assess
Crystal Structure of p110alpha complexed with niSH2 of p85alpha and PI-103 Heteromer
P27986; P42336;
8-1059
X6K;SO4;GOL;
Assess
Crystal structure of PI3K complex with an inhibitor Heteromer
P27986; P42336;
8-1059
84R;P6G;SO4;GOL;
Assess
The co-structure of N,N-dimethyl-4-[(6R)-6-methyl-5-(1H-pyrrolo[2,3- b]pyridin-4-yl)-4,5,6,7-tetrah… Heteromer
P27986; P42336;
2-1053
3K6;
Assess
The co-structure of 3-amino-6-(4-((1-(dimethylamino)propan-2-yl)sulfonyl)phenyl)-N-phenylpyrazine-2… Heteromer
P27986; P42336;
2-1053
8DY;
Assess
Crystal Structure of PI3Kalpha in complex with fragments 5 and 21 Heteromer
P27986; P42336;
1-1052
AX7;CAQ;
Assess
Crystal Structure of PI3Kalpha in complex with fragments 20 and 26 Heteromer
P27986; P42336;
1-1052
718;CL;SAL;
Assess
Crystal Structure of PI3Kalpha in complex with fragment 13 Heteromer
P27986; P42336;
5-1056
71J;
Assess
Crystal Structure of PI3Kalpha in complex with fragments 4 and 19 Heteromer
P27986; P42336;
1-1052
CL;70T;2ZV;
Assess
Crystal Structure of PI3Kalpha in complex with fragment 18 Heteromer
P27986; P42336;
1-1052
71K;
Assess
PI3K alpha in complex with an inhibitor Heteromer
P27986; P42336;
2-1052
KVJ;
Assess
Crystal Structure of p110alpha complexed with niSH2 of p85alpha Heteromer
P27986; P42336;
8-1058
SO4;
Assess
Crystal Structure of PI3Kalpha in complex with fragment 8 Heteromer
P27986; P42336;
2-1052
URF;
Assess
Crystal Structure of PI3Kalpha in complex with diC4-PIP2 Heteromer
P27986; P42336;
4-1053
PBU;PO4;
Assess
Human PI3K p85alpha/p110alpha H1047R bound to compound 2 Heteromer
P27986; P42336;
2-1050
UIW;
Assess
Crystal Structure of PI3Kalpha in complex with fragment 29 Heteromer
P27986; P42336;
3-1051
BHO;
Assess
PI3Ka H1047R co-crystal structure with inhibitor in cryptic pocket near H1047R (compound 7). Heteromer
P27986; P42336;
2-1049
YQ2;1LT;
Assess
Crystal structure of PI3K complex with an inhibitor Heteromer
P27986; P42336;
8-1055
84U;GOL;SO4;
Assess
Crystal structure of PI3K complex with an inhibitor Heteromer
P27986; P42336;
8-1055
84X;SO4;
Assess
Crystal Structure of PI3Kalpha in complex with fragment 9 Heteromer
P27986; P42336;
4-1051
HPP;
Assess
Crystal Structure of p110alpha in complex with niSH2 of p85alpha Heteromer
P27986; P42336;
6-1052
Assess
Crystal Structure of p110alpha complexed with niSH2 of p85alpha and compound 9d Heteromer
P27986; P42336;
8-1053
XXK;SO4;GOL;
Assess
Human PI3K p85alpha/p110alpha H1047R bound to compound 3 Heteromer
P27986; P42336;
5-1050
UJC;
Assess
PI 3-kinase alpha with nanobody 3-142, crosslinked with DSG Heteromer
P27986; P42336;
6-1051
Assess
Human PI3K p85alpha/p110alpha bound to RLY-2608 Heteromer
P27986; P42336;
5-1049
XUZ;
Assess
Human PI3K p85alpha/p110alpha H1047R bound to compound 1 Heteromer
P27986; P42336;
6-1050
UE9;
Assess
Cryo-EM structure of PI3Kalpha in complex with compound 18 Heteromer
P27986; P42336;
7-1050
L2V;
Assess
Cryo-EM structure of PI3Kalpha in complex with compound 16 Heteromer
P27986; P42336;
7-1050
7TZ;
Assess
Cryo-EM Structure of p110alpha in complex with p85alpha Heteromer
P27986; P42336;
7-1050
Assess
Cryo-EM structure of PI3Kalpha in complex with compound 17 Heteromer
P27986; P42336;
7-1050
7U5;
Assess
Structure of a human p110alpha/p85alpha complex Heteromer
P27986; P42336;
8-1050
Assess
Human PI3K p85alpha/p110alpha bound to compound 2 Heteromer
P27986; P42336;
8-1050
UIW;
Assess
Human PI3K p85alpha/p110alpha Heteromer
P27986; P42336;
11-1051
Assess
PI 3-kinase alpha with nanobody 3-142 Heteromer
P27986; P42336;
19-1059
Assess
p85alpha/p110alpha heterodimer H1047R mutant Heteromer
P27986; P42336;
11-1047
Assess
PI 3-kinase alpha with nanobody 3-126 Heteromer
P27986; P42336;
20-1053
Assess
Cryo-EM structure of p110alpha in complex with p85alpha inhibited by BYL-719 Heteromer
P27986; P42336;
18-1050
1LT;
Assess
Cryo-EM structure of cancer-specific PI3Kalpha mutant H1047R in complex with BYL-719 Heteromer
P27986; P42336;
19-1050
1LT;
Assess
CryoEM structure of PI3Kalpha Heteromer
P27986; P42336;
22-1053
Assess
PI 3-kinase alpha with nanobody 3-159 Heteromer
P27986; P42336;
26-1056
Assess
Crystal structure of HLA-A*03:01 in complex with a mutant PIK3CA peptide Heteromer
P04439; P42336; P61769;
1046-1054
GOL;FMT;
Assess
Crystal structure of HLA-A*03:01 in complex with a wild-type PIK3CA peptide Heteromer
P04439; P42336; P61769;
1046-1054
GOL;
Assess
Crystal structure of human 0606T1-2 TCR bound to HLA-A*03:01 in complex with a mutant PIK3CA peptide Heteromer
P04439; P42336; P61769;
1046-1054
13×GOL;
Assess
Crystal structure of human 21LT2-2 TCR bound to HLA-A*03:01 in complex with a mutant PIK3CA peptide Heteromer
P04439; P42336; P61769;
1046-1054
ACT;GOL;
Assess
Pi3K alpha lipid kinase with Active Site Inhibitormonomer2-1052
4EL;
Assess
HUMAN PI3KDELTA IN COMPLEX WITH COMPOUND 2Fmonomer107-1052
VBS;
Assess
Crystal structure of PI3K-alpha in complex with taselisibmonomer107-1051
799;
Assess
Human PI3Kalpha in complex with Compound 2-10 ((3S)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)…monomer107-1051
P5J;GOL;
Assess
p110alpha with GDC-0326monomer107-1051
5H5;EDO;
Assess
Crystal structure of PI3K-alpha in complex with compound 19monomer107-1051
X3W;
Assess
Crystal structure of PI3K-alpha in complex with compound 32monomer107-1051
X3N;
Assess
Crystal structure of PI3K alpha in complex with 3-(2-Amino-benzooxazol-5-yl)-1-isopropyl-1H-pyrazol…monomer107-1051
FE5;
Assess
Crystal structure of PI3K-alpha in complex with compound 30monomer107-1051
X3R;
Assess
Crystal structure of PI3K alpha in complex with 3-(2-Amino-benzooxazol-5-yl)-4-chloro-1-isopropyl-1…monomer107-1051
FDH;
Assess
Crystal structure of PI3K alpha in complex with 3-(2-Amino-benzooxazol-5-yl)-1-isopropyl-1H-pyrazol…monomer107-1051
FDW;
Assess
Crystal structure of PI3K alpha in complex with 3-(2-Amino-benzooxazol-5-yl)-1-isopropyl-4-methyl-1…monomer107-1051
FCZ;
Assess
CRYSTAL STRUCTURE OF PI3K ALPHA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1-YL)PHENYL)PYRROLO[2,1-F][1,2,4]…monomer107-1050
85S;
Assess
Cryo-EM structure of cancer-specific PI3Kalpha mutant E542K in complex with BYL-719monomer107-1050
1LT;
Assess
Cryo-EM structure of cancer-specific PI3Kalpha mutant E545K in complex with BYL-719monomer107-1050
1LT;
Assess
Crystal structure of the p110alpha catalytic subunit from homo sapiens in complex with activator 19…monomer107-1047
QIH;
Assess
Crystal structure of the apo p110alpha catalytic subunit from homo sapiensmonomer107-1046
Assess
Isolated p110a subunit of PI3Ka provides a platform for structure-based drug designmonomer107-1046
Assess
Isolated p110a subunit of PI3Ka provides a platform for structure-based drug designmonomer107-1046
ML9;
Assess
Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Kalp…monomer107-1046
KKR;
Assess
Crystal structure of human PI3Ka (p110a subunit) with MMV085400 bound to the active site determined…monomer107-1046
ZHY;
Assess
PQR530 [(S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-…monomer107-1046
M1J;
Assess
Crystal structure of PI3Kalpha selective Inhibitor PF-06843195monomer109-1047
VXY;
Assess
Structure of PIK3CA with covalent inhibitor 19monomer107-1045
2Q7;
Assess
Structure of PIK3CA with covalent inhibitor 22monomer107-1045
2IX;
Assess
Crystal structure of PI3Kalpha inhibitor 10-5429monomer109-1045
VY1;
Assess
Crystal structure of PI3Kalpha selective Inhibitor 11-1575monomer109-1045
VY4;
Assess
Crystal structure of PI3Kalpha inhibitor 4-0686monomer109-1044
VYP;
Assess
Solution structure of the C2 domain from human PI3-kinase p110 subunit alphamonomer331-481
Assess
Crystal structure of PI3K-alpha Ras Binding Domain (RBD)monomer157-300
Assess

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8dcp.1.Amonomer0.8520-1053
100.00
Assess
4l2y.1.Amonomer0.858-1053
XXK;100.00
Assess
5swt.1.Amonomer0.841-1054
71B;100.00
Assess